Pfenex selects Paragon for HHS anthrax vaccine manufacture
Pfenex has selected Paragon Bioservices to manufacture its Recombinant Protective Antigen (rPA) for an anthrax vaccine as it enters Phase I clinical trials.
Archives for November 6, 2013
ATMI begins strategic review but says bioreactors business is on track
ATMI has started exploring strategic alternatives but insists that its bioreactor business is positioned to benefit from increasing biopharma demand for single-use techs.
Applikon says new HQ will help meet biopharma demand
Bioreactor manufacturer Applikon Biotechnology has officially opened its new headquartered and manufacturing centre this week.
IBM's new hydrogel tech uses shear to make mAb delivery less stressful
A new vitamin E-based hydrogel technology could improve how cancer busting mAbs are delivered and help biopharmas cut costs according to developer IBM.
Repligen ups disposable chromatography column capacity
US biopharma company Repligen has completed a 9,000 square foot expansion of its facilities in Massachusetts to meet growing customer demand for disposable chromatography columns and warehousing.